During the last session, AbCellera Biologics Inc (NASDAQ:ABCL)’s traded shares were 1.1 million, with the beta value of the company hitting 0.37. At the end
In the last trading session, 1.3 million shares of the AbCellera Biologics Inc (NASDAQ:ABCL) were traded, and its beta was 0.36. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
